FindTrial
Sign In

Associated conflicts of interest among systematic review authors of long acting reversible contraceptives and the nature of the results and conclusions of these reviews

Associated conflicts of interest among systematic review authors of long acting reversible contraceptives and the nature of the results and conclusions of these reviews - Associated conflicts of interest among systematic review authors of long acting reversible contraceptives and the nature of the results and conclusions of these reviews

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000039680
Enrollment
Unknown
Registered
2020-03-03
Start date
2020-03-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

FCOI IN LARC

Interventions

None listed

Sponsors

Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma. 1111 W 17th St. Tulsa, OK 74107
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Furthermore, studies will be included which compare 1) LARCs to each other, 2) LARCs to oral contraceptives or 3) LARCs to nonpharmacologic therapy or placebo. Studies must have outcomes for one or more of the following 1) efficacy, 2) side effects including pain, nausea, weight gain, obesity, or preeclampsia etc 4) adverse events including complications, expulsion, perforation, infection, anemia, and/or bleeding, 5) application/insertion, or 6) promotion of use. Furthermore, to qualify for inclusion, systematic reviews must have been published from September of 2016 through January of 2020. Only systematic reviews published in English and reviews that synthesize studies of human or animal data will be included. Published poster presentations and conference abstracts will be excluded.

Exclusion criteria

Exclusion criteria: Furthermore, studies will be included which compare 1) LARCs to each other, 2) LARCs to oral contraceptives or 3) LARCs to nonpharmacologic therapy or placebo. Studies must have outcomes for one or more of the following 1) efficacy, 2) side effects including pain, nausea, weight gain, obesity, or preeclampsia etc 4) adverse events including complications, expulsion, perforation, infection, anemia, and/or bleeding, 5) application/insertion, or 6) promotion of use. Furthermore, to qualify for inclusion, systematic reviews must have been published from September of 2016 through January of 2020. Only systematic reviews published in English and reviews that synthesize studies of human or animal data will be included. Published poster presentations and conference abstracts will be excluded.

Design outcomes

Primary

MeasureTime frame
Thus, the purpose of this study is to evaluate potential conflicts of interest of reviewers in systematic reviews focused on long acting reversible contraceptives.—

Countries

North America

Contacts

Public Contactmicah hartwell

Oklahoma State University CHS

matt.vassar@okstate.edu9185948426

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026